Clinical Trial Update: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TQB2450 or placebo with Anlotinib, Etoposide, and Carboplatin versus Etoposide and Carboplatin in extensive small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Extensive Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN